© 1999 American Heart Association, Inc.
Original Contributions |
Cellular Cholesterol Transport and Efflux in Fibroblasts Are Abnormal in Subjects With Familial HDL Deficiency
From the Cardiovascular Genetics Laboratory (M.M., L.Y., L.K., B.B., J.S.C., J.G, Jr); the Clinical Research Institute of Montreal, Cardiology Services, Centre hospitalier de l'Université de Montréal (CHUM), Hôtel-Dieu Hospital (J.G., Jr); and the Montreal Heart Institute (M.M., J.G., Jr), Montréal, Québec, Canada, and from the Department of Medicine, University of Washington, Seattle (J.F.O.).
Correspondence to Jacques Genest, Jr, MD, Cardiovascular Genetics Laboratory, Clinical Research Institute of Montreal, Montréal, Québec, Canada H2W 1R7. E-mail genestj{at}ircm.umontreal.CA
Abstract—Familial high density
lipoprotein (HDL) deficiency (FHD) is a genetic lipoprotein
disorder characterized by a severe decrease in the plasma HDL
cholesterol (-C) level (less than the fifth percentile).
Unlike Tangier disease, FHD is transmitted as an autosomal dominant
trait. FHD subjects have none of the clinical manifestations of Tangier
disease (lymphoid tissue infiltration with cholesteryl esters and/or
neurological manifestations). Plasmas from FHD subjects contain
pre–ß-migrating HDLs but are deficient in 
-migrating HDLs. We
hypothesized that a reduced HDL-C level in FHD is due to abnormal
transport of cellular cholesterol to the plasma membrane,
resulting in reduced cholesterol efflux onto nascent HDL
particles, leading to lipid-depleted HDL particles that are rapidly
catabolized. Cellular cholesterol metabolism
was investigated in skin fibroblasts from FHD and control subjects.
HDL3- and apolipoprotein (apo) A-I–mediated cellular
cholesterol and phosphatidylcholine efflux was examined by
labeling cells with [3H]cholesterol and
[3H]choline, respectively, during growth and
cholesterol loading during growth arrest. FHD cells
displayed an 
25% reduction in HDL3-mediated cellular
cholesterol efflux and an 50% to 80% reduction in
apoA-I–mediated cholesterol and phosphatidylcholine efflux
compared with normal cells. Cellular cholesterol ester
levels were decreased when cholesterol-labeled cells were
incubated with HDL3 in normal cells, but
cholesterol ester mobilization was significantly reduced in
FHD cells. HDL3 binding to fibroblasts and the possible
role of the HDL binding protein/vigilin in FHD were also investigated.
No differences were observed in 125I-HDL3
binding to LDL-loaded cells between FHD and control cells. HDL binding
protein/vigilin mRNA levels and its protein expression were
constitutively expressed in FHD cells and could be modulated (2-fold
increase) by elevated cellular cholesterol in normal cells.
In conclusion, FHD is characterized by reduced HDL3- and
apoA-I–mediated cellular cholesterol efflux. It is not
associated with abnormal cellular HDL3 binding or a defect
in a putative HDL binding protein.
Key Words: apolipoprotein A-I • cholesterol efflux • HDL deficiency • coronary artery disease
This article has been cited by other articles:
 |
|
 |
|
  I. Iatan, Z. Dastani, R. Do, D. Weissglas-Volkov, I. Ruel, J. C. Lee, A. Huertas-Vazquez, M.-R. Taskinen, A. Prat, N. G. Seidah, et al. Genetic Variation at the Proprotein Convertase Subtilisin/Kexin Type 5 Gene Modulates High-Density Lipoprotein Cholesterol Levels Circ Cardiovasc Genet, October 1, 2009; 2(5): 467 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kralova Lesna, P. Suchanek, J. Kovar, P. Stavek, and R. Poledne Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport J. Lipid Res., November 1, 2008; 49(11): 2414 - 2418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Kiss, N. Kavaslar, K.-i. Okuhira, M. W. Freeman, S. Walter, R. W. Milne, R. McPherson, and Y. L. Marcel Genetic Etiology of Isolated Low HDL Syndrome: Incidence and Heterogeneity of Efflux Defects Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1139 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Berrougui, M. Isabelle, M. Cloutier, G. Grenier, and A. Khalil Age-related impairment of HDL-mediated cholesterol efflux J. Lipid Res., February 1, 2007; 48(2): 328 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Haidar, R. S. Kiss, L. Sarov-Blat, R. Brunet, C. Harder, R. McPherson, and Y. L. Marcel Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux J. Biol. Chem., December 29, 2006; 281(52): 39971 - 39981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Jiang, B. Lu, P. Kim, P. M. Elias, and K. R. Feingold Regulation of ABCA1 expression in human keratinocytes and murine epidermis J. Lipid Res., October 1, 2006; 47(10): 2248 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kontush and M. J. Chapman Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis Pharmacol. Rev., September 1, 2006; 58(3): 342 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rashid, B. W. Patterson, and G. F. Lewis Thematic review series: Patient-Oriented Research. What have we learned about HDL metabolism from kinetics studies in humans? J. Lipid Res., August 1, 2006; 47(8): 1631 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Y. Lee, A. Lesimple, M. Denis, J. Vincent, A. Larsen, O. Mamer, L. Krimbou, J. Genest, and M. Marcil Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B J. Lipid Res., March 1, 2006; 47(3): 622 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Dastani, L. Quiogue, C. Plaisier, J. C. Engert, M. Marcil, J. Genest, and P. Pajukanta Evidence for a Gene Influencing High-Density Lipoprotein Cholesterol on Chromosome 4q31.21 Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 392 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. L. Ruel, P. Couture, J. S. Cohn, A. Bensadoun, M. Marcil, and B. Lamarche Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism J. Lipid Res., August 1, 2004; 45(8): 1528 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Haidar, M. Denis, M. Marcil, L. Krimbou, and J. Genest Jr. Apolipoprotein A-I Activates Cellular cAMP Signaling through the ABCA1 Transporter J. Biol. Chem., March 12, 2004; 279(11): 9963 - 9969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Alenezi, M. Marcil, D. Blank, M. Sherman, and J. Genest Jr. Is the Decreased High-Density Lipoprotein Cholesterol in the Metabolic Syndrome Due to Cellular Lipid Efflux Defect? J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 761 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Krimbou, M. Marcil, H. Chiba, and J. Genest Jr. Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles J. Lipid Res., May 1, 2003; 44(5): 884 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Marcil, R. Bissonnette, J. Vincent, L. Krimbou, and J. Genest Cellular Phospholipid and Cholesterol Efflux in High-Density Lipoprotein Deficiency Circulation, March 18, 2003; 107(10): 1366 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Sniderman, Z. Zhang, J. Genest, and K. Cianflone Effects on apoB-100 secretion and bile acid synthesis by redirecting cholesterol efflux from HepG2 cells J. Lipid Res., March 1, 2003; 44(3): 527 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Haidar, M. Denis, L. Krimbou, M. Marcil, and J. Genest Jr. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts J. Lipid Res., December 1, 2002; 43(12): 2087 - 2094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Reddy, S. Hama, C. Ng, V. Grijalva, M. Navab, and A. M. Fogelman ATP-Binding Cassette Transporter 1 Participates in LDL Oxidation by Artery Wall Cells Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1877 - 1883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Baranova, T. Vishnyakova, A. Bocharov, Z. Chen, A. T. Remaley, J. Stonik, T. L. Eggerman, and A. P. Patterson Lipopolysaccharide Down Regulates Both Scavenger Receptor B1 and ATP Binding Cassette Transporter A1 in RAW Cells Infect. Immun., June 1, 2002; 70(6): 2995 - 3003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Oram and R. M. Lawn ABCA1: the gatekeeper for eliminating excess tissue cholesterol J. Lipid Res., August 1, 2001; 42(8): 1173 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Thibault, P. Tardif, and G. Lapalme Comparative Specificity of Platelet {alpha}IIb{beta}3 Integrin Antagonists J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 690 - 696. [Abstract] [Full Text]
|
|
|
|
|
|
B. Haidar, S. Mott, B. Boucher, C. Y. Lee, M. Marcil, and J. Genest , Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts J. Lipid Res., February 1, 2001; 42(2): 249 - 257. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. W. Freeman Effluxed lipids: Tangier Island's latest export PNAS, September 28, 1999; 96(20): 10950 - 10952. [Full Text] [PDF]
|
|
|
|
|
|
Y. Takahashi and J. D. Smith Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway PNAS, September 28, 1999; 96(20): 11358 - 11363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Costet, Y. Luo, N. Wang, and A. R. Tall Sterol-dependent Transactivation of the ABC1 Promoter by the Liver X Receptor/Retinoid X Receptor J. Biol. Chem., September 1, 2000; 275(36): 28240 - 28245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Chen, D. L. Silver, J. D. Smith, and A. R. Tall Scavenger Receptor-BI Inhibits ATP-binding Cassette Transporter 1- mediated Cholesterol Efflux in Macrophages J. Biol. Chem., September 29, 2000; 275(40): 30794 - 30800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Singaraja, V. Bocher, E. R. James, S. M. Clee, L.-H. Zhang, B. R. Leavitt, B. Tan, A. Brooks-Wilson, A. Kwok, N. Bissada, et al. Human ABCA1 BAC Transgenic Mice Show Increased High Density Lipoprotein Cholesterol and ApoAI-dependent Efflux Stimulated by an Internal Promoter Containing Liver X Receptor Response Elements in Intron 1 J. Biol. Chem., August 31, 2001; 276(36): 33969 - 33979. [Abstract] [Full Text] [PDF]
|
|